title: [Feasibility and technical problems of sentinel node analysis in melanoma].
abstract: BACKGROUND
  Development of the sentinel lymph node (SLN) biopsy the last 10 years has changed surgical approach of solid tumor treatment and particularly of melanoma. The aim of our study was to analyze in our hospital, the feasibility of the SLN biopsy technique in order to define a better prognostic classification of melanomas.
  
  
  METHODS
  Between July 1999 and October 2003, 97 patients were included in this study in our center. Criteria for inclusion were cutaneo-mucosal melanoma of Breslow >or=1,5 mm, and/or Clarck >or=IV, and/or ulceration, and/or signs of regression, before any surgical margins.
  
  
  RESULTS
  Lymphoscintigraphy (LS) identified at least 1 SLN in 94 cases/97 (97%), thus permitting intraoperative SLN mapping and sentinel node biopsy of at least 1 lymph node in 88 cases/94 (94%). Failure of the SLN procedure was noted in 9 cases: in 3 cases, no lymph node was individualized by LS, in 1 patient, intraoperative SLN mapping failed to find the previously identified SLN and in 5 cases, a SLN was identified by LS and intraoperative mapping but could not be removed because of its deep location and difficulty of dissection. In 17 patients, removal of one or two "non sentinel lymph node(s)" was (were) made by the surgeon because of its (their) suspected aspect (black or large). Among the 88 patients who had dissection of at least 1 SLN, a micrometastasis was detected by standard histological evaluation and/or immunohistochemical stains in 14 cases (16%) and into a "non SLN" in 2 cases (2,3%). The median follow up of patients was 16 months (1- 48 months). Among the 14 patients with positive SLN, 6 (43%) relapsed. The other eight were in complete remission of their melanoma with a mean follow up of 11,44 months . Among the 74 patients with negative SLN, 7 (9,5%) developed a recurrence. Among the 9 patients in whom any sentinel lymph node have been removed, 3 had a relapse (one in transit than on lymph nodes, and two on lymph nodes).
  
  
  CONCLUSIONS
  Our results are in accordance with the literature, and confirm the feasibility of SLN mapping and of SLN histological analysis in our center. We described in this study technical problems we encountered. Our study also show the prognostic value of this technique. However, advantage in global survey of sentinel node dissection and regional lymph node dissection in cases of micrometastases has still to be demonstrated.
authors.affiliation: Service de dermatologie-II, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75475 Paris cedex 10, France.
authors.forename: A
authors.initials: A
authors.lastname: Mebazaa
authors.forename: D
authors.initials: D
authors.lastname: Kerob
authors.forename: M-E
authors.initials: ME
authors.lastname: Toubert
authors.forename: O
authors.initials: O
authors.lastname: Verola
authors.forename: J-M
authors.initials: JM
authors.lastname: Servant
authors.forename: M
authors.initials: M
authors.lastname: Baccard
authors.forename: C
authors.initials: C
authors.lastname: Billotey
authors.forename: K
authors.initials: K
authors.lastname: Bustamante
authors.forename: F-O
authors.initials: FO
authors.lastname: Vandici
authors.forename: N
authors.initials: N
authors.lastname: Basset-Seguin
authors.forename: L
authors.initials: L
authors.lastname: Ollivaud
authors.forename: P
authors.initials: P
authors.lastname: Morel
authors.forename: C
authors.initials: C
authors.lastname: Lebbé
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008545:Melanoma / Q000473:pathology*; D008875:Middle Aged; D011379:Prognosis; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000473:pathology*